Dr. Palaty obtained a PhD in Pharmaceutical Sciences from the University of BC in 1995. He received his certification in Clinical Biochemistry from the Canadian Academy of Clinical Biochemists (CACB) in 2001.
Dr. Palaty has worked as a lab technologist at WorkSafe BC and clinical biochemist at BC Children’s Hospital. He has worked at LifeLabs (or its subsidiary, the former BC Biomedical) since 2005, with a particular interest in clinical applications of mass spectrometry.
- Canadian Academy of Clinical Biochemists Fellow. Jan 2001
- PhD, University of British Columbia. 1995
- MSc, University of British Columbia. 1990
- BSc, University of British Columbia. 1987
- Horvath GA, Davidson AG, Stockler-Ipsiroglu SG, Lillquist YP, Waters PJ, Olpin S, Andresen BS, Palaty J, Nelson J, Vallance H. Newborn screening for MCAD deficiency: experience of the first three years in British Columbia, Canada. Can J Public Health. 2008 Jul-Aug;99(4):276-80.
- Copes R, Clark NA, Rideout K, Palaty J, Teschke K. Uptake of cadmium from Pacific oysters (Crassostrea gigas) in British Columbia oyster growers. Environ Res. 2008 Jun;107(2):160-9.
- Leary SC, Cobine PA, Kaufman BA, Guercin GH, Mattman A, Palaty J, Lockitch G, Winge DR, Rustin P, Horvath R, Shoubridge EA. The human cytochrome c oxidase assembly factors SCO1 and SCO2 have regulatory roles in the maintenance of cellular copper homeostasis. Cell Metab. 2007 Jan;5(1):9-20. Erratum in: Cell Metab. 2007 May;5(5):403.
- Innis SM, Palaty J, Vaghri Z, Lockitch G. Increased levels of mercury associated with high fish intakes among children from Vancouver, Canada. J Pediatr. 2006 Jun;148(6):759-63.
- Nuttall KL, Palaty J, Lockitch G. Reference limits for copper and iron in liver biopsies. Ann Clin Lab Sci. 2003 Fall;33(4):443-50.
- Urine drug testing
- substance use disorders
- bone metabolism
- Specialty: Clinical Biochemistry
- Currently: Clinical mass spectrometry applications
- Formerly: Clinical trace metals testing and newborn screening